Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000245182 | SCV000319588 | likely benign | Cardiovascular phenotype | 2019-12-05 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000461069 | SCV000717471 | likely benign | not provided | 2018-09-25 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV000769417 | SCV000900810 | likely benign | Cardiomyopathy | 2017-08-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001473627 | SCV001677781 | likely benign | Hypertrophic cardiomyopathy 14 | 2024-12-17 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV002222461 | SCV002500509 | benign | not specified | 2022-03-19 | criteria provided, single submitter | clinical testing |